The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...

This interview accompanies the third podcast in our National Recovery Month series with Kim MacDonald-Wilson, ScD, CPRP, ...

Rachel Dalthorp, MD, discusses how zuranolone (Zurzuvae) can improve postpartum depression when compared with previous ...

Joseph Alvarnas, MD, of City of Hope, recaps yesterday's Institute for Value-Based Medicine® (IVBM) event on value-based oncology care, emphasizing patient-centered approaches and how attendees can ...

Anant Madabhushi, PhD, executive director for the Emory Empathetic AI for Health Institute, discusses the potential of ...

More than 25 million people lost their Medicaid coverage during the unwinding process conducted by all states after the ...

Physicians in the US, Germany, and France show gaps in their knowledge of the treatment of of refractory/relapsed chronic ...

The impact alopecia areata (AA) has on patients' health-related quality of life (HRQOL) may not be accurately measured with ...

Clinical decision-making can be difficult for patients with SMA due to the lack of clinical trials comparing treatment ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

On this episode of Managed Care Cast, we're talking with the author of a study published in the September 2024 issue of The ...

Results show that cognitive decline, combined with factors like smoking, obesity, and chronic health conditions, sharply ...